These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36144393)

  • 41. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey.
    Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME
    Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dominance of international high-risk clones in carbapenemase-producing
    Pragasam AK; Veeraraghavan B; Anandan S; Narasiman V; Sistla S; Kapil A; Mathur P; Ray P; Wattal C; Bhattacharya S; Deotale V; Subramani K; Peter JV; Hariharan TD; Ramya I; Iniyan S; Walia K; Ohri VC
    Indian J Med Microbiol; 2018; 36(3):344-351. PubMed ID: 30429385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital.
    Sekiguchi J; Teruya K; Horii K; Kuroda E; Konosaki H; Mizuguchi Y; Araake M; Kawana A; Yoshikura H; Kuratsuji T; Miyazaki H; Kirikae T
    J Infect Chemother; 2007 Dec; 13(6):418-22. PubMed ID: 18095093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of carbapenemases bla
    Haider MH; McHugh TD; Roulston K; Arruda LB; Sadouki Z; Riaz S
    Ann Clin Microbiol Antimicrob; 2022 May; 21(1):18. PubMed ID: 35590320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elucidating the virulence genes harboured by carbapenemase- and non-carbapenemase-producing carbapenem-resistant
    Al Fadhli AH; Jamal WY; Rotimi VO
    J Med Microbiol; 2022 Jul; 71(7):. PubMed ID: 35819900
    [No Abstract]   [Full Text] [Related]  

  • 46. Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
    Hernández-García M; García-Castillo M; García-Fernández S; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Vieira AR; Ramalheira E; Sancho L; Diogo J; Ferreira R; Silva T; Chaves C; Bou G; Cercenado E; Delgado-Valverde M; Oliver A; Pitart C; Rodríguez-Lozano J; Tormo N; Romano J; Pássaro L; Paixão L; López-Mendoza D; Díaz-Regañón J; Cantón R;
    J Antimicrob Chemother; 2021 Jan; 76(2):370-379. PubMed ID: 33099623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sink drains as reservoirs of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in a Belgian intensive care unit: relation to patients investigated by whole-genome sequencing.
    De Geyter D; Vanstokstraeten R; Crombé F; Tommassen J; Wybo I; Piérard D
    J Hosp Infect; 2021 Sep; 115():75-82. PubMed ID: 34111433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biofilm Formation and Virulence Factors Among Pseudomonas aeruginosa Isolated From Burn Patients.
    Ghanbarzadeh Corehtash Z; Khorshidi A; Firoozeh F; Akbari H; Mahmoudi Aznaveh A
    Jundishapur J Microbiol; 2015 Oct; 8(10):e22345. PubMed ID: 26587205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
    Nouér SA; Nucci M; de-Oliveira MP; Pellegrino FL; Moreira BM
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3663-7. PubMed ID: 16127037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular surveillance of carbapenemase-producing
    Schäfer E; Malecki M; Tellez-Castillo CJ; Pfennigwerth N; Marlinghaus L; Higgins PG; Mattner F; Wendel AF
    Antimicrob Resist Infect Control; 2019; 8():208. PubMed ID: 31893042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
    Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
    Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Whole-Genome Sequencing Elucidates the Epidemiology of Multidrug-Resistant
    Mao P; Deng X; Yan L; Wang Y; Jiang Y; Zhang R; Yang C; Xu Y; Liu X; Li Y
    Front Microbiol; 2021; 12():715568. PubMed ID: 34589072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital.
    Jayakumar S; Appalaraju B
    Indian J Pathol Microbiol; 2007 Oct; 50(4):922-5. PubMed ID: 18306607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in Kunming.
    Fan X; Wu Y; Xiao M; Xu ZP; Kudinha T; Bazaj A; Kong F; Xu YC
    Sci Rep; 2016 May; 6():26522. PubMed ID: 27198004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
    de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
    Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New genotyping method discovers sustained nosocomial Pseudomonas aeruginosa outbreak in an intensive care burn unit.
    Tissot F; Blanc DS; Basset P; Zanetti G; Berger MM; Que YA; Eggimann P; Senn L
    J Hosp Infect; 2016 Sep; 94(1):2-7. PubMed ID: 27451039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of two multidrug-resistant Pseudomonas aeruginosa clonal lineages with a countrywide distribution in Hungary.
    Libisch B; Balogh B; Füzi M
    Curr Microbiol; 2009 Feb; 58(2):111-6. PubMed ID: 18946702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multidrug-resistant Pseudomonas aeruginosa in healthcare facilities in Port-au-Prince, Haiti.
    McAulay K; Schuetz AN; Fauntleroy K; Shen L; Merveille YM; Deroncelay A; Cole N; Fitzgerald DW; Ocheretina O
    J Glob Antimicrob Resist; 2021 Jun; 25():60-65. PubMed ID: 33662645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidrug-Resistance Genes in Pseudomonas aeruginosa from Wound Infections in a Tertiary Health Institution in Osogbo, Nigeria.
    Akinloye AO; Adefioye JO; Adekunle CO; Anomneze BU; Makanjuola OB; Onaolapo OJ; Onaolapo AY; Olowe OA
    Infect Disord Drug Targets; 2021; 21(1):90-98. PubMed ID: 31957616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
    Martins N; Martins IS; de Freitas WV; de Matos JA; Girão VB; Coelho-Souza T; Maralhães AC; Cacci LC; de Figueiredo MP; Dias RC; Costa-Lourenço AP; Ferreira AL; Dalla-Costa L; Nouér SA; Santoro-Lopes G; Riley LW; Moreira BM
    Microb Drug Resist; 2013 Jun; 19(3):216-23. PubMed ID: 23336529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.